Andreas Halvorsen's position in BridgeBio Pharma is currently worth $973M. That's 2.51% of their equity portfolio (13th largest holding). The investor owns 7.35% of the outstanding BridgeBio Pharma stock. Andreas Halvorsen started to build up the position in BridgeBio Pharma in Q2 2019. Since then they sold 12.2M shares. The stake costed the investor $397M, netting the investor a gain of 145% so far.